Incyte Corp (INCY)
51.65
-0.27
(-0.52%)
USD |
NASDAQ |
Apr 23, 16:00
51.85
+0.20
(+0.39%)
Pre-Market: 08:00
Incyte Cash from Operations (Quarterly): 147.73M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 147.73M |
| September 30, 2023 | 147.84M |
| June 30, 2023 | 306.53M |
| March 31, 2023 | -105.60M |
| December 31, 2022 | 283.66M |
| September 30, 2022 | 296.38M |
| June 30, 2022 | 174.16M |
| March 31, 2022 | 215.74M |
| December 31, 2021 | 115.35M |
| September 30, 2021 | 255.10M |
| June 30, 2021 | 172.94M |
| March 31, 2021 | 206.10M |
| December 31, 2020 | 107.32M |
| September 30, 2020 | 182.12M |
| June 30, 2020 | 269.38M |
| March 31, 2020 | -683.42M |
| December 31, 2019 | 131.62M |
| September 30, 2019 | 270.42M |
| June 30, 2019 | 152.96M |
| March 31, 2019 | 155.66M |
| December 31, 2018 | 83.84M |
| September 30, 2018 | 199.15M |
| June 30, 2018 | 32.40M |
| March 31, 2018 | 20.84M |
| December 31, 2017 | -89.27M |
| Date | Value |
|---|---|
| September 30, 2017 | 53.12M |
| June 30, 2017 | 116.79M |
| March 31, 2017 | -173.64M |
| December 31, 2016 | 94.38M |
| September 30, 2016 | 95.27M |
| June 30, 2016 | 17.57M |
| March 31, 2016 | 97.54M |
| December 31, 2015 | 72.88M |
| September 30, 2015 | 7.723M |
| June 30, 2015 | 13.39M |
| March 31, 2015 | -4.586M |
| December 31, 2014 | 44.72M |
| September 30, 2014 | 27.79M |
| June 30, 2014 | -14.56M |
| March 31, 2014 | -31.69M |
| December 31, 2013 | -11.69M |
| September 30, 2013 | -11.95M |
| June 30, 2013 | 8.081M |
| March 31, 2013 | 24.74M |
| December 31, 2012 | -22.01M |
| September 30, 2012 | -27.14M |
| June 30, 2012 | 8.724M |
| March 31, 2012 | -54.40M |
| December 31, 2011 | -39.78M |
| September 30, 2011 | -46.98M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-683.42M
Minimum
Mar 2020
306.53M
Maximum
Jun 2023
139.28M
Average
174.16M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Novartis AG | 2.547B |
| MorphoSys AG | -- |
| Illumina Inc | 224.00M |
| Biogen Inc | 12.50M |
| Pfizer Inc | 5.24B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -154.50M |
| Cash from Financing (Quarterly) | 0.346M |
| Free Cash Flow | 449.00M |
| Free Cash Flow Per Share (Quarterly) | 0.6424 |
| Free Cash Flow to Equity (Quarterly) | 145.46M |
| Free Cash Flow to Firm (Quarterly) | 145.46M |
| Free Cash Flow Yield | 3.85% |